phase readout
saveNCT04699630: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
COMPLETEDupdated 14d ago
community read0 votes
Sponsor: SCRI Development Innovations, LLC. Phase: PHASE2. Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that